Skip to main content
Efficacy of Etanercept in the Treatment of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Efficacy of Etanercept in the Treatment of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
User login
Username
Password
Reset your password
Concept
Lead
score
Biologic Therapy
1
0.66
Stevens-Johnson Syndrome
0
0.46
Hospital
0
0.39
Toxicology
0
0.38
Intravenous Immunoglobulin (IVIG)
0
0.36
Intravenous
0
0.31
Toxic Epidermal Necrolysis
0
0.31
Anti-Tumor Necrosis Factor (Anti-TNF)
0
0.26
California
0
0.23
Specialty
Lead
score
Dermatology
1
1
Allergy & Clinical Immunology
0
1
Emergency Medicine
0
1
Internal Medicine
0
1
Pharmacist
0
1
Family Medicine/Primary Care
0
0.95
Hospital Medicine
0
0.87
Public Health & Prevention
0
0.85
Infectious Diseases
0
0.52
Rheumatology
0
0.41
Hematology-Oncology
0
0.4
Nursing
0
0.4
Cardiology
0
0.35
Orthopaedics
0
0.35
Critical Care
0
0.33
General Surgery
0
0.27
Pathology & Lab Medicine
0
0.26
Transplantation
0
0.26